- Presence of excess extracellular fluid in at least two fetal compartments (ascites, pleural effusion, pericardial effusion, skin edema, polyhydramnios) without any identifiable circulating antibody to red-cell antigens.
- For a discussion on immune-mediated disease, see Chapter 37.
- Prevalence is estimated at 1:1500-4000.
- Highest prevalence in Southeast Asian population.
Affected System | Approx. % of Cases (in third trimester) | Examples | |
---|---|---|---|
Cardiac | 20% | Fetal arrhythmias (bradyarrhythmias and tachyarrhythmias) Structural cardiac defects causing congestive failure Extrinsic compression of heart causing low output states → leads to fetal tachyarrhythmia → high-output failure → hydrops Myocarditis | |
Renal | 5% | Nephrosis Renal hypoplasia/aplasia | Renal vein thrombosis Obstructive uropathies |
Infection | 8% | Toxoplasmosis Herpes simplex virus Syphilis Adenovirus | Rubella CMV Hepatitis Parvovirus |
Pulmonary | 5% | Congenital chylothorax Pulmonary lymphangiectasia | Congenital diaphragmatic hernia Cystic adenomatoid malformations |
Other intrathoracic masses (eg, pulmonary sequestration) that cause compression of thoracic blood vessels → obstructive venous flow → hydrops | |||
Placenta/cord | Rare | Chorangioma Arteriovenous malformation Significant cord compression | Umbilical vein thrombosis True umbilical cord knot |
Maternal conditions | 5% | Diabetes mellitus Severe preeclampsia/ eclampsia | Hyperthyroidism |
Gastrointestinal | 5% | In utero midgut volvulus | Bowel atresias |
Chromosomal | 10% | Turner syndrome Aneuploidy | Trisomies 13, 18, 21 Noonan Syndrome |
Miscellaneous | 10% | Congenital myopathies Inborn errors of metabolism CNS malformations | Skeletal dysplasias Abdominal neoplasms |
Unknown | 20% |
- Increased uterine size for dates
- Decreased fetal movements
- Generalized maternal edema (mirror syndrome)
- Polyhydramnios (AFI >24)
- Placentomegaly
- Infants with nonimmune hydrops are at very high risk for fetal demise.
- Intrauterine therapy is aimed at treating underlying causes (maternal digitalis therapy for fetal tachyarrhythmias); if this is not possible, the risks of intrauterine death versus premature delivery have to be weighed.
- By organ system (see table below).
System | Potential Difficulties/Management |
---|---|
Pulmonary |
|
Cardiovascular |
|
Fluids and electrolytes |
|
| |
Hematology |
|
Infectious disease |
|
Renal |
|